key: cord-1020410-g2kchohc
authors: Nalleballe, Krishna; Siddamreddy, Suman; Kovvuru, Sukanthi; Veerapaneni, Poornachand; Roy, Bhaskar; Onteddu, Sanjeeva Reddy
title: Risk of coronavirus disease 2019 (COVID-19) from hospital admission during the pandemic
date: 2020-10-08
journal: Infection control and hospital epidemiology
DOI: 10.1017/ice.2020.1249
sha: eca1184cd6af5d87fbf3c5f2e5385cb625c0d135
doc_id: 1020410
cord_uid: g2kchohc

nan

2020, and June 30, 2020. Among them, 44 patients (0.043%) tested positive for COVID-19 by RT-PCR within 14 days of discharge (see Table 1 for demographics and comorbidities). The percentage of positive COVID-19 patients among the total US population was 1.0353% (3, 416 ,428 of 329,986,480) as of July 14, 2020.The odds of contracting COVID-19 is 24.1 times higher in the general population compared to hospitalized patients (OR, 24.1; 95% CI, 17.9-32.4; P < .001).

Overall, this result suggests a low risk of COVID-19 from hospitalization. The proper use of PPE and appropriate precautionary measures may have helped reduce the risk of transmission of COVID-19 during hospitalization. Despite addressing a relevant question, our study has several limitations. Some SARS-CoV-2- 

Stroke care and the COVID19 pandemic words from our president. World Stroke Organization website. www.world-stroke.org/ news-and-blog/news/stroke-care-and-the-covid19-pandemic

Underutilization of healthcare for strokes during the COVID-19 outbreak

Reduced rate of hospital admissions for ACS during COVID-19 outbreak in northern Italy

US and world population clock. US Census Bureau website

Acknowledgments. Data for the study were provided by the Arkansas Clinical Data Repository (AR-CDR) maintained by the Department of Biomedical Informatics in the College of Medicine at the University of Arkansas for Medical Sciences (UAMS). The AR-CDR is approved to operate as an enterprise data resource to support research across UAMS.Financial support. No financial support was provided relevant to this article.Conflicts of interest. B.R. received a consulting fee from Alexion pharmaceutical. All other authors report no conflicts of interest.